Tuberculosis 8 Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to action

Grants

Funding Acknowledgements

BIM and PRO have no financial support or other conflicts of interest to declare; MCR is head of the Stop TB Partnership; ADH is senior advisor to the International Union Against Tuberculosis and Lung disease (The Union); ALK works with the Brazilian Tuberculosis Research Network (Rede-TB); SMG chairs the lung health section of the International Union Against Tuberculosis and Lung disease (The Union); WME directs the International Center for AIDS Care and Treatment Programs and receives support from the US President's Emergency Plan For AIDS Relief (PEPFAR); MH directs the Treatment Action Group; GC directs the Aurum Institute for Health Research; PM is involved in University of Zambia-University College London Medical School Research and Training Projects; IS receives support from PEPFAR; SHEK is co-inventor of the rBCG Delta UreC:Hly vaccine candidate and member of the Scientific Advisory Boards of Intercell, and Vaccine Project Management; CJMW is a Chief Scientific Advisor at the UK Department for International Development; RA is Director of Strategy, Performance and Evaluation at the Global Fund to Fight AIDS, Tuberculosis and Malaria; AZ receives support from the European Union Framework Programme 7, European Developing Country Clinical Trials Partnership, Global Alliance for TB Drug development, EuropeAID Active Detection of Active TB Project, UK Medical Research Council, and National Institute of Health Research, University College London Hospitals NHS Trust-Comprehensive Biomedical Research Centre.